05/19/2026
The FDA has approved Idvynso, which combines two drugs made by Merck—doravirine (which has been available for several years under the brand name Pifeltro) + islatravir, the first of a new drug class, nucleoside reverse transcriptase translocation inhibitors.
positivelyaware.com/fda-approves-idvynso